<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="11" ids="22586">Antioxidants</z:chebi>, such as <z:chebi fb="122" ids="21241">vitamins C</z:chebi> and E, have been proposed for the treatment of <z:hpo ids='HP_0000726'>dementia</z:hpo> disorders </plain></SENT>
<SENT sid="1" pm="."><plain>Although other vitamins and trace elements may also have <z:chebi fb="11" ids="22586">antioxidant</z:chebi>-enhancing activities, it is not known whether the overall <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status in <z:hpo ids='HP_0000726'>dementia</z:hpo> patients is associated with the intake level of these vitamins and trace elements </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we assessed the levels of vitamins and trace elements in the diet of patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD), and <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>) and a group of carers, along with blood levels of total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity (<z:chebi fb="44" ids="53498">TAC</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>Results show that the dietary intake was decreased for most measured vitamins and trace elements in severe AD, but not in other <z:hpo ids='HP_0000726'>dementia</z:hpo> groups </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, we found no significant difference in the levels of <z:chebi fb="44" ids="53498">TAC</z:chebi> between any of the <z:hpo ids='HP_0000726'>dementia</z:hpo> groups </plain></SENT>
<SENT sid="5" pm="."><plain>There was, however, a significant correlationbetween intake of <z:chebi fb="5" ids="33283">vitamin B1</z:chebi>, <z:chebi fb="9" ids="17439">vitamin B12</z:chebi>, zinc, and <z:chebi fb="19" ids="27568">selenium</z:chebi> and blood levels of <z:chebi fb="44" ids="53498">TAC</z:chebi> in the VaD group, but not in the AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> groups </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, no association was observed in any of the <z:hpo ids='HP_0000726'>dementia</z:hpo> groups between zinc and copper intake and Cu/Zn <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase activity, or between dietary <z:chebi fb="19" ids="27568">selenium</z:chebi> intake and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase activity </plain></SENT>
<SENT sid="7" pm="."><plain>The activities of these two endogenous <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes do not seem to be influenced by intake levels of relevant substances </plain></SENT>
<SENT sid="8" pm="."><plain>The data indicate that the influence of dietary vitamins and metal ions on the overall <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status is limited to VaD patients only </plain></SENT>
<SENT sid="9" pm="."><plain>Clinical trials are needed to ascertain the value of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> supplementation in VaD patients </plain></SENT>
</text></document>